SK Biopharm’s Hefty IPO To Support Novel Anti-Epileptic, Pipeline

Bellwether Of Post-COVID Sentiment

 
• By Jung Won Shin
  
Dollar bills
SK’s Successful IPO To Speed Up Offerings By Other Biotechs
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia